<div id="readability-page-1"><p>GRIMES &amp; Co WEALTH MANAGEMENT LLC acquired a new position in  Cardinal Health, Inc. (NYSE:CAH - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,192 shares of the company's stock, valued at approximately $815,000.</p><div><p><span></span><span>Get <strong>Cardinal Health</strong> alerts:</span></p></div><ul><li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li></ul><p>Several other institutional investors have also added to or reduced their stakes in CAH. SJS Investment Consulting Inc. raised its stake in shares of  Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company's stock worth $25,000 after purchasing an additional 150 shares during the last quarter.  Jones Financial Companies Lllp increased its holdings in  Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock worth $27,000 after buying an additional 14,034 shares in the last quarter.  Atlantic Edge Private Wealth Management LLC raised its position in  Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company's stock worth $29,000 after buying an additional 75 shares during the last quarter.  Vermillion &amp; White Wealth Management Group LLC lifted its stake in  Cardinal Health by 55.0% during the 2nd quarter. Vermillion &amp; White Wealth Management Group LLC now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 71 shares during the period.  Finally, Quent Capital LLC bought a new position in  Cardinal Health during the 3rd quarter valued at about $35,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>Analyst Ratings Changes</h2><p>CAH has been the subject of a number of research analyst reports. Wells Fargo &amp; Company lifted their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an &#34;overweight&#34; rating in a research note on Wednesday, November 5th. UBS Group lifted their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a &#34;buy&#34; rating in a research report on Friday, October 31st. Mizuho  set a $222.00 price target on Cardinal Health in a report on Monday. Wall Street Zen raised Cardinal Health from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a report on Saturday, November 8th. Finally, Evercore ISI upped their price objective on Cardinal Health from $190.00 to $220.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 31st. Fourteen investment analysts have rated the stock with a Buy rating and two have issued  a Hold rating to the stock. According to MarketBeat, Cardinal Health  has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $214.07.</p><ul><li>Medical Technology Stock Benefits from Rising Acute Care Demand</li></ul><p><b>Get Our Latest Stock Report on CAH</b></p><h2>Cardinal Health Stock Up 2.7%</h2><p>NYSE CAH opened at $208.08 on Wednesday. Cardinal Health, Inc. has a 52 week low of $119.92 and a 52 week high of $214.93. The company has a market capitalization of $49.44 billion, a P/E ratio of 31.38, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65. The stock's 50-day moving average price is $204.54 and its 200-day moving average price is $173.77. </p><ul><li>For Cardinal Health, the Proof Will be in Its Performance</li></ul><p>Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the prior year, the firm posted $1.88 EPS. The firm's quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS.  Research analysts anticipate that  Cardinal Health, Inc. will post 7.95 EPS for the current year. </p><h2>Cardinal Health Dividend Announcement</h2><p>The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health's dividend payout ratio  is currently 30.77%. </p><h2>Cardinal Health News Summary</h2><p>Here are the key news stories impacting Cardinal Health this week:</p><ul>   <li><span>Positive Sentiment: </span>Cardinal raised FY‑2026 EPS guidance to at least $10, cited accelerating specialty revenue (&gt;$50B target) and announced strategic wins (IRA transition, new ContinuCare™ Pathway and a Publix partnership) — the core catalyst cited by management at J.P. Morgan. <i></i><span>PR Newswire: Cardinal Health Raises Fiscal 2026 Outlook</span></li>    <li><span>Positive Sentiment: </span>Major business-media pieces note the guidance raise and specialty growth narrative as the reason for the stock jump and upgraded investor sentiment. <i></i><span>Benzinga: Cardinal Health Lifts 2026 Profit Outlook</span></li>    <li><span>Positive Sentiment: </span>Barron’s explained why the guidance lift and specialty revenue trajectory make 2026 a constructive year for the stock, reinforcing buy‑side interest. <i></i><span>Barron's: Cardinal Health Stock Jumps on Guidance Raise</span></li>    <li><span>Neutral Sentiment: </span>The company’s full J.P. Morgan presentation/transcript provides detail on strategy execution and was used to support the guidance update; useful for modeling but not new on the headline guidance. <i></i><span>Seeking Alpha: J.P. Morgan Presentation Transcript</span></li>    <li><span>Neutral Sentiment: </span>Analyst coverage and fair‑value views are shifting upward as sell‑side models incorporate the stronger FY26 guide and specialty momentum. <i></i><span>Yahoo Finance: Analyst Upgrades &amp; Specialty Focus</span></li>    <li><span>Negative Sentiment: </span>Short interest rose materially in December (≈23.6% increase to ~6.06M shares), which can add downside risk or volatility if sentiment reverses. (No article link provided)</li>    <li><span>Negative Sentiment: </span>Some commentary questions valuation after a multi‑year run and steep share gains — investors should weigh the beat/guidance versus premium multiples. <i></i><span>Yahoo Finance: Has Cardinal Health Run Too Far?</span></li> </ul><h2>Cardinal Health Company Profile</h2> (Free Report)<p>Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.  </p><p>The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Cardinal Health</li><li>This $15 Stock Could Go Down as the #1 Stock of 2026</li><li>“Ominous day” coming to stocks…</li><li>Punch these codes into your ordinary brokerage account</li><li>The Crash Has Already Started (Most Just Don’t See It Yet)</li><li>A month before the crash</li></ul><p><strong>Want to see what other hedge funds are holding CAH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2><p>Before you consider Cardinal Health, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>GRIMES & Co WEALTH MANAGEMENT LLC has acquired a new position in Cardinal Health, Inc. (NYSE:CAH), purchasing 5,192 shares valued at approximately $815,000. This acquisition is part of a trend where several institutional investors have increased their stakes in Cardinal Health. Analysts have raised their price targets for the stock, with a consensus rating of "Moderate Buy" and a target price of $214.07. Cardinal Health recently reported strong earnings, exceeding estimates, and announced a quarterly dividend of $0.5107, reflecting a yield of 1.0%.</p>

GRIMES & Co WEALTH MANAGEMENT LLC Purchases New Position in Cardinal Health, Inc. $CAH